Frank M. Longo active positions
| Companies | Position | Start | End |
|---|---|---|---|
PharmatrophiX, Inc.
 PharmatrophiX, Inc. BiotechnologyHealth Technology PharmatrophiX, Inc. develops a drug technology targeting neurodegenerative disorders. The firm is currently focusing on Alzheimer''s disease treatment. It has two development programs, p75 receptor program and Trk ligand program which targets a spectrum of neurological and non-neurological disorders. The company was founded by Frank M. Longo in 2005 and is headquartered in Raleigh, NC. | Chairman | 2004-12-31 | - |
| Founder | 2004-12-31 | - | |
| Stanford University | Corporate Officer/Principal | 2005-12-31 | - |
Career history of Frank M. Longo
Training of Frank M. Longo
| University of California San Diego | Doctorate Degree |
| Harvard T.H. Chan School of Public Health | Graduate Degree |
Statistics
International
| United States | 5 |
Operational
| Doctorate Degree | 2 |
| Chairman | 1 |
| Founder | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
PharmatrophiX, Inc.
PharmatrophiX, Inc. BiotechnologyHealth Technology PharmatrophiX, Inc. develops a drug technology targeting neurodegenerative disorders. The firm is currently focusing on Alzheimer''s disease treatment. It has two development programs, p75 receptor program and Trk ligand program which targets a spectrum of neurological and non-neurological disorders. The company was founded by Frank M. Longo in 2005 and is headquartered in Raleigh, NC. | Health Technology |
- Stock Market
- Insiders
- Frank M. Longo
- Experience
